Edition:
United Kingdom

Celyad SA (CYAD.BR)

CYAD.BR on Brussels Stock Exchange

18.38EUR
25 Apr 2019
Change (% chg)

-- (--)
Prev Close
€18.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,591
52-wk High
€32.96
52-wk Low
€15.10

About

Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. The Company's product, C-Cure,... (more)

Overall

Beta: 1.65
Market Cap(Mil.): €493.66
Shares Outstanding(Mil.): 9.52
Dividend: --
Yield (%): --

Financials

  CYAD.BR Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -2.24 -- --
ROI: -17.72 8.91 13.83
ROE: -24.26 10.06 15.25

Earnings vs. Estimates